Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01205217 | Lapatinib or Trastuzumab Given Prior to Surgery With Chemotherapy in Patients With Early Breast Cancer(ELATE) | withdrawn | Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 4 | Jun 7, 2017 | clinicaltrials |
| NCT02483871 | Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy | withdrawn | Phase 1 | 0 | Duke UniversityOTHER | 1 | Jun 5, 2017 | clinicaltrials |
| NCT01361945 | AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Texas Tech University Health Sciences Center, El PasoOTHER | 0 | May 9, 2017 | clinicaltrials |
| NCT01784042 | Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02621099 | Hybrid Gamma Camera in Breast Surgery(HICAM) | withdrawn | — | 0 | University of NottinghamOTHER | 1 | May 5, 2017 | clinicaltrials |
| NCT01227408 | Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT01029977 | Imaging Modality Effects on the Multi-dimensional InfraRed Analysis (MIRA) Technology | withdrawn | — | 0 | Real Imaging Ltd.INDUSTRY | 1 | Apr 27, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT00397501 | BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain | withdrawn | Phase 1 / Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Apr 21, 2017 | clinicaltrials |
| NCT01681901 | Ultrasound in Detecting Lymph Node Metastasis in Older Patients Undergoing Breast Sonography | withdrawn | — | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Apr 13, 2017 | clinicaltrials |
| NCT01729832 | Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer | withdrawn | N/A | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 0 | Apr 13, 2017 | clinicaltrials |
| NCT02067637 | Delayed Effects of Treatment in Cancer Survivors (DETECS)(DETECS) | withdrawn | — | 0 | University of Colorado, DenverOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00993642 | ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer | withdrawn | Early Phase 1 | 0 | Tulane University Health Sciences CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT02685306 | A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer | withdrawn | Phase 2 | 0 | Peregrine PharmaceuticalsINDUSTRY | 0 | Mar 9, 2017 | clinicaltrials |
| NCT01302821 | C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast Cancer | withdrawn | N/A | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT02616224 | A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer | withdrawn | — | 0 | Hoffmann-La RocheINDUSTRY | 0 | Feb 23, 2017 | clinicaltrials |
| NCT01640847 | MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases | withdrawn | Phase 2 | 0 | ImunonINDUSTRY | 0 | Feb 7, 2017 | clinicaltrials |
| NCT02432118 | Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Feb 2, 2017 | clinicaltrials |
| NCT00695916 | MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery | withdrawn | Phase 3 | 0 | Stanford UniversityOTHER | 0 | Feb 1, 2017 | clinicaltrials |
| NCT01780532 | Photoacoustic Imaging (PAI) of Suspicious Breast Cancers - A Clinical Feasibility Study | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jan 30, 2017 | clinicaltrials |
| NCT01959867 | SurgiMend in Two-stage Implant-based Breast Reconstruction in Patients With Pre-Mastectomy Radiotherapy | withdrawn | N/A | 0 | Integra LifeSciences CorporationINDUSTRY | 0 | Jan 10, 2017 | clinicaltrials |
| NCT02661100 | A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients | withdrawn | Phase 1 / Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT00450515 | Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer | withdrawn | Phase 2 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Dec 6, 2016 | clinicaltrials |
| NCT01738685 | Intervention to Improve Self-Care of Symptoms in Breast Cancer Survivors on Adjuvant Endocrine Therapy(Relief) | withdrawn | N/A | 0 | University of PittsburghOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02058667 | Reirradiation With Concurrent Paclitaxel for Breast Cancer | withdrawn | Phase 1 | 0 | University of KentuckyOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT02759549 | Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH | withdrawn | N/A | 0 | Emory UniversityOTHER | 1 | Nov 15, 2016 | clinicaltrials |
| NCT00774241 | PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01156961 | A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX) | withdrawn | Phase 4 | 0 | Hoffmann-La RocheINDUSTRY | 0 | Nov 2, 2016 | clinicaltrials |
| NCT01943240 | Pectoral Nerve Blockade in Mastectomy | withdrawn | Phase 4 | 0 | Timothy R PetersenOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT01479179 | Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 26, 2016 | clinicaltrials |
| NCT01756092 | Treatment of Benign Breast Deformities and Post-Segmental Mastectomy Breast Deformities With Autologous Fat Grafting (AFT) | withdrawn | N/A | 0 | University of PittsburghOTHER | 1 | Oct 21, 2016 | clinicaltrials |
| NCT02610621 | Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy | withdrawn | Phase 2 | 0 | Cedars-Sinai Medical CenterOTHER | 1 | Oct 13, 2016 | clinicaltrials |
| NCT02725541 | Trial of Neoadjuvant Trastuzumab Emtansine in Patients With HER2-Equivocal Breast Cancer(NATURE) | withdrawn | Phase 2 | 0 | Jenny C. Chang, MDOTHER | 1 | Sep 14, 2016 | clinicaltrials |
| NCT02102438 | Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | withdrawn | N/A | 0 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00692458 | A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT02183597 | Whole-body MRI for the Detection of Metastasis(WBMRI) | withdrawn | — | 0 | Norwegian University of Science and TechnologyOTHER | 0 | Aug 10, 2016 | clinicaltrials |
| NCT02539017 | The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer | withdrawn | Phase 2 | 0 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02639611 | Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders | withdrawn | N/A | 0 | NYU Langone HealthOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT02429544 | Effects of a Group Residential Retreat on Cancer Outcomes | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 1, 2016 | clinicaltrials |
| NCT02627430 | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 26, 2016 | clinicaltrials |
| NCT01360177 | Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00053339 | Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00934401 | Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer | withdrawn | — | 0 | University of IowaOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT02637375 | A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer | withdrawn | N/A | 0 | University of ChicagoOTHER | 0 | May 30, 2016 | clinicaltrials |
| NCT01016028 | Chemotherapy-Induced Peripheral Neuropathy Survey | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | May 3, 2016 | clinicaltrials |
| NCT02338531 | Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer(RHEA) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 2 | Apr 29, 2016 | clinicaltrials |
| NCT02215876 | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer | withdrawn | Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 15, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jun 7, 2017source: clinicaltrials